Enrolling by invitationPhase 3NCT06044337
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
Studying Chronic cutaneous lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Biogen
- Principal Investigator
- Medical DirectorBiogen
- Intervention
- BIIB059 (litifilimab)(drug)
- Enrollment
- 322 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2029
Study locations (30)
- Arizona Arthritis & Rheumatology Research, PLLC, Phoenix, Arizona, United States
- Dermatology Research Associates, Los Angeles, California, United States
- Inland Rheumatology Clinical Trials, Inc., Upland, California, United States
- David Fivenson, MD, Dermatology, PLLC, Ann Arbor, Michigan, United States
- Revival Research Institute, LLC, Troy, Michigan, United States
- Saint Louis University, St Louis, Missouri, United States
- Thurston Arthritis Research Center, Chapel Hill, North Carolina, United States
- Duke Dermatology South Durham, Durham, North Carolina, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
- Precision Comprehensive Clinical Research Solutions, Grapevine, Texas, United States
- Instituto CAICI, Rosario, Santa Fe Province, Argentina
- Investigaciones Clinicas Tucuman, San Miguel de Tucumán, Tucumán Province, Argentina
- Centro de Investigaciones Medicas Tucuman, San Miguel de Tucumán, Tucumán Province, Argentina
- APRILLUS Asistencia e Investigacion, Buenos Aires, Argentina
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06044337 on ClinicalTrials.govOther trials for Chronic cutaneous lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)EMD Serono Research & Development Institute, Inc.
- RECRUITINGPHASE2NCT06980805A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)Immunovant Sciences GmbH
- RECRUITINGPHASE1NCT06013995A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of LupusBristol-Myers Squibb